• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axogen Inc (NQ: AXGN )

    9.270 -0.180 (-1.90%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 162,559
    Open 9.440
    Bid (Size) 9.260 (2)
    Ask (Size) 9.270 (33)
    Prev. Close 9.450
    Today's Range 9.190 - 9.570
    52wk Range 3.450 - 10.83
    Shares Outstanding 41,397,053
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Axogen, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +34.15%
    +34.15%
    1 Month
    +28.22%
    +28.22%
    3 Month
    +33.00%
    +33.00%
    6 Month
    +4.63%
    +4.63%
    1 Year
    +6.55%
    +6.55%

    More News

    Read More
    Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Earnings Preview
    Via Benzinga
    Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
    From Axogen, Inc.
    Via GlobeNewswire
    AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Axogen, Inc Reports First Quarter 2024 Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 5, 2024
    Via Benzinga
    Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
    From Axogen, Inc.
    Via GlobeNewswire
    Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Announces Promotions on Research and Development Team
    From Axogen, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.